Issue of Share Options

Summary by AI ^BETAClose X

Avingtrans Plc has granted options over 293,000 ordinary shares at an exercise price of 515.0 pence per share to non-PDMR employees under its Share Option Plan. These options are subject to a three-year vesting period and a performance condition requiring adjusted earnings per share growth to at least match the increase in the Retail Prices Index.

Disclaimer*

Avingtrans PLC

12 January 2026

Avingtrans Plc

("Avingtrans", the "Company", or the "Group")

Issue of Share Options

Avingtrans plc (the "Company") announces that on 12 January 2026, RemCo, in accordance with the Company's Share Option Plan, granted options over 293,000 ordinary shares of 5 pence each in the Company (the "Ordinary Shares") with an exercise price of 515.0 pence per Ordinary Share (the "Option Awards") to non-PDMR employees.

The options may not be exercised until three years from the date of grant and are subject to a performance condition, being that the increase in the Company's adjusted earnings per share must be at least equal to the increase in the Retail Prices Index over the vesting period.

Enquiries:

Avingtrans plc	01354 692 391
Roger McDowell, Chairman Steve McQuillan, Chief Executive Officer Stephen King, Chief Financial Officer
Singer Capital Markets (Nominated Adviser and Broker)	020 7496 3000
Sara Hale
Alex Bond
Carl Diebitsch
IFC Advisory (Financial PR)	020 3934 6630
Graham Herring Tim Metcalfe Zach Cohen

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END